Delivery Order 36F79723D0188-70FA4024F00000238
Award Date 5/1/24
Potential Completion Date 6/1/24
Potential Value $19K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20472, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, to purchase NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The contract has a firm fixed price of $15,921.60 and a completion date of May 31, 2024. Emergent Devices holds multiple federal contracts and grant sub-awards to supply naloxone products, including NARCAN, to various government...
- This federal contract award is for the delivery of NALOXONE INTERNASAL SPRAY in support of NATIONAL FENTANYL OPERATIONS, with a ceiling value of $19,900.32. The contract was awarded to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer specializing in medical countermeasures, primarily naloxone products used to reverse opioid overdoses. The contract is a Delivery Order issued by the Department of Homeland Security's Immigration and Customs Enforcement (ICE) agency, with a place...
- The Department of Homeland Security's Customs and Border Protection awarded Emergent Devices, Inc., a for-profit manufacturer, a $152,712 firm-fixed-price delivery order contract for NARCAN, a naloxone nasal spray used to rapidly reverse opioid overdoses. This order was placed against Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceutical and hematology products, which runs through August 2028. Emergent Devices has previously provided NARCAN to other federal agencies,...
- This is a firm-fixed price delivery order awarded by the Department of Justice Bureau of Prisons Federal Correctional Institution Ashland to Emergent Devices, Inc. (also known as Emergent BioSolutions), a for-profit manufacturer, for the supply of NARCAN (naloxone nasal spray). The order, valued at $1,356.84, is being awarded under Emergent Devices' Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and has an expected completion date of October 31, 2024. This contract...
- This is a $455,898.24 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Emergent Devices, Inc., a pharmaceutical manufacturer, for the supply of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has an ultimate completion date of August 17, 2016 and was awarded on August 10, 2016 without any set-aside designation. Emergent Devices, a subsidiary of Emergent BioSolutions, is a key supplier of naloxone...
- The U.S. Immigration and Customs Enforcement (ICE) awarded a Firm Fixed Price Delivery Order to Emergent Devices, Inc., a manufacturer of pharmaceutical products, for the provision of NARCAN (naloxone nasal spray) with a potential value of $101,310.72. The order was placed under Emergent Devices' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). NARCAN is an emergency medication used to rapidly reverse opioid overdoses. Emergent Devices has previously received...
- This federal contract award was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs (VA). The $130,256.64 firm-fixed-price delivery order was awarded to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the supply of NALOXONE HCL 4MG. Emergent Devices, a subsidiary of Emergent BioSolutions, is a key supplier of opioid overdose reversal medications to various federal agencies, including the VA,...
- This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The contract is a $934,875.00 delivery order under Emergent Devices' Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs, which runs through August 2028. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has also received other...
- This is a federal delivery order awarded by the Department of Health and Human Services Indian Health Service to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical products. The $178,164.00 contract is for the purchase of NARCAN nasal spray, a medication that rapidly reverses opioid overdoses. This delivery order is placed against Emergent Devices' Federal Supply Schedule (FSS-61-IB) contract for pharmaceuticals and drugs. No set-aside designation was used. Emergent Devices...
- The Department of Veterans Affairs Veterans Health Administration awarded Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, a firm-fixed-price delivery order contract to provide naloxone nasal spray. The $904,465.44 contract is under the Pharmaceuticals and Drugs Federal Supply Schedule 61-IB, which allows Emergent Devices to furnish drugs and hematology products to VA facilities through 2028. The naloxone nasal spray rapidly reverses opioid overdoses and treats substance...